or Try an Advanced Search...

    ETF Components for LABU - Direxion Daily S&P Biotech Bull 3X Shares


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    EXAS C -0.12 2.58
    GILD A 0.12 2.01
    ALNY B 0.37 1.87
    UTHR B -0.15 1.86
    VKTX D -2.07 1.82
    ABBV A -0.26 1.79
    NTRA B 0.19 1.76
    AMGN D -0.59 1.74
    REGN D -0.41 1.72
    INCY B 2.97 1.55
    VRTX D 1.01 1.54
    SRPT F -2.05 1.52
    BMRN F -0.27 1.33
    BIIB F -1.57 1.33
    CYTK F -0.38 1.24
    NBIX F -0.93 1.22
    PCVX B 1.11 0.93
    EXEL C 1.35 0.79
    MRNA F -4.34 0.78
    CRSP F -2.98 0.76
    APLS F -3.81 0.73
    MDGL F -1.36 0.72
    TGTX C -2.39 0.72
    BPMC F -2.70 0.71
    HALO D -1.05 0.69
    INSM D -0.16 0.69
    RVMD B -0.40 0.69
    ALKS C 3.00 0.68
    KRYS D -0.31 0.64
    RARE C 1.73 0.61
    IONS F -2.47 0.60
    BBIO F -2.59 0.59
    IOVA F -0.43 0.58
    ACLX C -2.48 0.58
    NUVL B 0.70 0.56
    CRNX D 1.60 0.50
    SWTX F 0.56 0.47
    ADMA B -1.10 0.46
    ACAD F -0.52 0.42
    FOLD F -0.19 0.42
    DYN D -3.23 0.42
    CLDX F -4.68 0.42
    TWST D -3.94 0.41
    RNA A 5.62 0.41
    VERA C -3.10 0.41
    NTLA F -6.57 0.40
    DNLI C -1.58 0.39
    GERN D -2.86 0.37
    BEAM F -4.45 0.36
    KYMR C -1.61 0.36
    IDYA F -3.00 0.35
    IMVT F -0.21 0.34
    SMMT D -8.22 0.34
    RYTM C -1.18 0.33
    CPRX C 1.71 0.32
    ARDX D -0.58 0.32
    BCRX D -2.89 0.31
    VCYT C -2.67 0.31
    JANX D -2.05 0.31
    PTCT C -2.83 0.30
    NRIX D -1.69 0.29
    DVAX D 1.44 0.29
    AGIO D -4.41 0.29
    NVAX D -2.45 0.28
    PTGX C -1.40 0.28
    SNDX F 3.32 0.27
    KROS C 2.96 0.27
    AKRO C 0.49 0.27
    ARWR F -0.98 0.26
    VRDN B 3.78 0.26
    VCEL F -5.21 0.26
    ARQT D 2.69 0.23
    RXRX F -6.37 0.23
    MIRM D 2.87 0.22
    TVTX C 0.00 0.22
    CDNA C -0.96 0.22
    MYGN D -1.31 0.22
    RCKT F -7.31 0.21
    KURA D -1.69 0.21
    MNKD C -0.48 0.20
    PRTA F -0.48 0.18
    CDMO C -3.43 0.18
    XNCR D -2.34 0.17
    DAWN D 0.50 0.17
    CGON C -2.20 0.16
    COGT C -0.46 0.16
    IRWD F -2.43 0.15
    IMNM F -7.52 0.15
    CGEM F 0.12 0.15
    ANAB D 3.91 0.15
    ARCT D 8.79 0.14
    FDMT F -3.70 0.14
    ALT F 2.44 0.14
    RCUS F 0.85 0.13
    SANA F 1.92 0.12
    RLAY F -7.49 0.12
    RGNX F -2.67 0.11
    OLMA D 3.02 0.11
    VIR F 0.93 0.10
    IRON C 7.31 0.10
    CCCC F -2.46 0.10
    ETNB F -0.54 0.10
    SPRY C -0.28 0.10
    ALLO F -4.64 0.10
    STOK D 0.65 0.10
    AVXL D -4.23 0.10
    ORIC D -2.05 0.10
    SRRK F -6.99 0.09
    OCGN F -4.25 0.08
    SAGE F -3.60 0.08
    FATE F -4.29 0.08
    VERV F -1.03 0.07
    EDIT F -4.11 0.07
    MDXG F -0.17 0.07
    ZNTL D -2.99 0.06
    SCLX F -3.85 0.06
    VYGR F 0.00 0.05
    HUMA D 1.01 0.05
    ALEC F -2.36 0.05
    SVRA D -5.90 0.05
    ITOS F -2.06 0.04
    CABA F -1.69 0.04
    HRTX F 0.50 0.04

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Medicine Biology Immunology Disease Immune System Organ Systems Clinical Development Antibodies Solid Tumors Monoclonal Antibodies Monoclonal Antibody Autoimmune Disease Enzymes Genetics Infectious Diseases
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Drug Manufacturers - General Medical Devices

    Recent News for Direxion Daily S&P Biotech Bull 3X Shares & its Holdings

    Date Stock Title
    Oct 1 GILD $1000 Invested In This Stock 20 Years Ago Would Be Worth $8,800 Today
    Oct 1 ARCT Unveiling 3 Analyst Insights On Arcturus Therapeutics
    Oct 1 MYGN Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
    Oct 1 ABBV Should You Buy AbbVie Stock After Recent Parkinson's Study Success?
    Oct 1 MRNA The Covid Era Tech Promises To Reinvent Cancer Treatment
    Oct 1 SRPT Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
    Oct 1 ABBV AbbVie withdraws Exviera from EU market for commercial reasons
    Oct 1 APLS Apellis Pharmaceuticals: Assessing The Impact Of The Negative CHMP Opinion
    Oct 1 BMRN 3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)
    Oct 1 CPRX Catalyst (CPRX) Upgraded to Buy: What Does It Mean for the Stock?
    Oct 1 BMRN BMRN or MYGN: Which Is the Better Value Stock Right Now?
    Oct 1 MYGN BMRN or MYGN: Which Is the Better Value Stock Right Now?
    Oct 1 AMGN Fresenius Kabi wins FDA approval for Stelara biosimilar Otulfi
    Oct 1 ARCT ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
    Oct 1 MRNA ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
    Oct 1 MRNA Is Moderna, Inc. (MRNA) the Worst Performing Stock to Buy on the Dip?
    Oct 1 PTCT PTC Therapeutics brain disorder therapy granted FDA review
    Oct 1 MRNA MRNA Begins Dosing in Pivotal Study on Norovirus Vaccine
    Oct 1 GERN High Growth Tech Stocks To Watch This October 2024
    Oct 1 IMVT Is Immunovant, Inc. (IMVT) the Worst Performing Stock to Buy on the Dip?
    The investment seeks daily investment results, of 300% of the performance of the S&P Biotechnology Select Industry Index ("index"). The index is provided by S&P and includes domestic companies from the biotechnology industry. The fund normally creates long positions by investing at least 80% of its assets in the securities that comprise the index and/or financial instruments that provide leveraged and unleveraged exposure to the index. These financial instruments include: swap agreements; options on securities and indices; forward contracts; reverse repurchase agreements; ETFs; and other financial instruments. The fund is non-diversified.
    Exchange Traded Fund ETF Exchange Traded Funds Index Fund Biotechnology Leveraged ETF Ultra ETF S&P 500 Index CBOE Repurchase Agreement Forward Contract
    Back to the Main LABU Page...